Summary Tocagen Inc (Tocagen) is a clinical-stage cancer-selective gene therapy company that develops and commercializes product candidates for the treatment of cancer.The company offers lead product candidate such as Toca 511 and Toca FC, which is being investigated for the treatment of recurrent and metastatic cancers.
It uses cancer-selective gene therapy platform built on retroviral replicating vectors (RRVs) which are designed to deliver therapeutic genes into the DNA of cancer cells.The company is developing Toca 511 and Toca FC in a Phase 1b clinical trial for metastatic cancers, including colorectal, pancreatic, breast, lung, melanoma, and renal.
It also offers other RRVs to deliver genes to cancer cells against validated immunotherapy targets, such as the checkpoint protein PD-L1. Tocagen is headquartered in San Diego, California, the US.
Tocagen Inc (TOCA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
275 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
"Selective Estrogen Receptor Degrader (SERDs) Market, Dosage, Price & Clinical Trials Insight 2025" Report Highlights: • Global SERD Market Opportunity: > US$ 2 Billion By 2025 • USA To dominate Global SERD Market • SERD In Clinical Trials: > 15 Drugs • Detailed Clinical insight on All Drugs in clinical...
The global banana powder market reached a value of US$ 990.6 Million in 2020. Bananas represent the world’s most consumed fresh fruit and the fourth most important food crop in terms of the gross value of production. Unlike raw bananas, banana powder has a shelf-life of almost two years when stored in a cold storage facility in the absence...
Pharmaceutical Analytical Testing Market Report Overview Pharmaceutical Analytical Testing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pharmaceutical Analytical Testing market types and applications. It is a focused study on Pharmaceutical...
The North America medical cyclotron market is expected to reach US$ 109.15 million by 2027 from US$ 80.99 million in 2019; it is estimated to grow at a CAGR of 3.9% from 2020 to 2027. The growth of the market is attributed to key driving factors such as increasing prevalence of cancer and growing inclination toward nuclear scans for accurate...
The water soluble polymer market is expected to register a CAGR of over 4% during the forecast period. The factors driving the growth of the market studied are the growing shale gas industry in North America and the water treatment industry in the Asia-Pacific region. - On the flip side, other than the impact of COVID-19 pandemic on...
Report Scope: This report provides detailed exposure to the Pharma 4.0 market. This report also highlights the current and future market potential of Pharma 4.0 along with a detailed analysis of the competitive environment, regulatory scenario, technological advancement, and drivers, restraints, opportunities and trends...
A laboratory information management system (LIMS) is a type of application that is designed to enhance laboratory quality and performance by keeping track of data relating to samples, tests, workflows, and equipment.Cloud LIMS and data integration analysis are driving demand for LIMS across the world.Pharmaceuticals and life sciences applications...
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Active Pharmaceutical Ingredients Market 2021-2025
The analyst has been monitoring the active pharmaceutical ingredients market and it is poised to grow by $ 64.53 bn during 2021-2025, progressing at a CAGR of 6% during the forecast period. Our report on the active pharmaceutical ingredients market provides a holistic...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.